Nuvalent Stock (NASDAQ: NUVL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 390.25K |
Day Range | - - - |
52 Wk Range | 39.86 - 89.39 |
Market Cap | $5.33B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 35.7% |
Days to Cover | 15.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nuvalent (NASDAQ:NUVL) through any online brokerage.
Other companies in Nuvalent’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Ionis Pharmaceuticals (NASDAQ:IONS).
There is no analysis for Nuvalent.
Nuvalent has a consensus price target of $87.55.
The stock price for Nuvalent (NASDAQ: NUVL) is $82.51 last updated July 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Nuvalent.
Nuvalent’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Nuvalent.
Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.